It is assumed that systemic administration of NK cells would be disadvantageous for reaching the target organs, considering the tumor microenvironment (TME) in which cytolytic effectors including NK and CD8+ T cells have low capacity to infiltrate (19). This evidence concerns the gene CD8A and neoplasm.